Precursor Cell Lymphoblastic Leukemia-Lymphoma

"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Descriptor ID	D054198
MeSH Number(s)	C04.557.337.428.600 C15.604.515.560.600 C20.683.515.528.600
Concept/Terms	Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia Lymphoma Leukemia, Acute Lymphoblastic Acute Lymphoblastic Leukemia Leukemia, Lymphoblastic Leukemia, Lymphoblastic, Acute Leukemia, Lymphocytic, Acute Lymphoblastic Leukemia Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Lymphocytic Leukemia, Acute Acute Lymphocytic Leukemia Leukemia, Acute Lymphocytic Lymphoma, Lymphoblastic Acute Lymphoid Leukemia Leukemia, Acute Lymphoid Lymphoid Leukemia, Acute Leukemia, Lymphoid, Acute Leukemia, Lymphocytic, Acute, L1 Leukemia, Lymphocytic, Acute, L1 Lymphocytic Leukemia, L1 L1 Lymphocytic Leukemia Leukemia, L1 Lymphocytic Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia, Acute, L1 ALL, Childhood Childhood ALL Leukemia, Lymphoblastic, Acute, L1 Leukemia, Lymphocytic, Acute, L2 Leukemia, Lymphocytic, Acute, L2 Lymphocytic Leukemia, L2 L2 Lymphocytic Leukemia Leukemia, L2 Lymphocytic Lymphoblastic Leukemia, Acute, Adult Lymphoblastic Leukemia, Acute, L2 Leukemia, Lymphoblastic, Acute, L2 Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Leukemia [C04.557.337]
Leukemia, Lymphoid [C04.557.337.428]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C04.557.337.428.600]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Leukemia, Lymphoid [C15.604.515.560]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C15.604.515.560.600]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Leukemia, Lymphoid [C20.683.515.528]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600]

Below are MeSH descriptors whose meaning is related to "Precursor Cell Lymphoblastic Leukemia-Lymphoma".

Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.

Bar chart showing 32 publications over 16 distinct years, with a maximum of 4 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	2	2
1997	1	1	2
1999	2	0	2
2001	3	0	3
2002	2	0	2
2005	1	0	1
2006	2	0	2
2009	2	0	2
2010	1	1	2
2011	1	0	1
2016	3	0	3
2019	0	1	1
2020	1	1	2
2021	4	0	4
2023	2	0	2

Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.

Swain RM, Sanchez A, Gutierrez DA, Varela-Ramirez A, Aguilera RJ. Thiophene derivative inflicts cytotoxicity via an intrinsic apoptotic pathway on human acute lymphoblastic leukemia cells. PLoS One. 2023; 18(12):e0295441.

View in: PubMed
Montes-Rodr?guez IM, Soto-Salgado M, Torres-Cintr?n CR, Tomassini-Fernandini JC, Su?rez E, Clavell LA, Cadilla CL. Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012-2016. Cancer Epidemiol Biomarkers Prev. 2023 08 01; 32(8):1030-1037.

View in: PubMed
Ayala-Marin YM, Grant AH, Rodriguez G, Kirken RA. Quadruple and Truncated MEK3 Mutants Identified from Acute Lymphoblastic Leukemia Promote Degradation and Enhance Proliferation. Int J Mol Sci. 2021 Nov 11; 22(22).

View in: PubMed
Grant AH, Ayala-Marin YM, Mohl JE, Robles-Escajeda E, Rodriguez G, Dutil J, Kirken RA. The Genomic Landscape of a Restricted ALL Cohort from Patients Residing on the U.S./Mexico Border. Int J Environ Res Public Health. 2021 07 09; 18(14).

View in: PubMed
Apostolidou E, Lachowiez C, Juneja HS, Qiao W, Ononogbu O, Miller-Chism CN, Udden M, Ma H, Mims MP. Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clin Lymphoma Myeloma Leuk. 2021 11; 21(11):e895-e902.

View in: PubMed
Kashanian SM, Holtzman NG, Patzke CL, Cornu J, Duffy A, Koka M, Niyongere S, Duong VH, Baer MR, Apata J, Kamangar F, Emadi A. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemother Pharmacol. 2021 06; 87(6):817-826.

View in: PubMed
Bencomo-Alvarez AE, Gonzalez MA, Rubio AJ, Olivas IM, Lara JJ, Padilla O, Orazi A, Corral J, Philipovskiy A, Gaur S, Mulla ZD, Dwivedi AK, Eiring AM. Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study. Cancer. 2021 04 01; 127(7):1068-1079.

View in: PubMed
Khalife R, Montroy J, Grigor EJM, Fergusson DA, Atkins H, Seftel M, Presseau J, Thavorn K, Holt RA, Hay K, Lalu MM, Kekre N. Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study. Br J Haematol. 2020 10; 191(1):e14-e19.

View in: PubMed
Grigor EJM, Fergusson D, Kekre N, Montroy J, Atkins H, Seftel MD, Daugaard M, Presseau J, Thavorn K, Hutton B, Holt RA, Lalu MM. Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2019 04; 33(2):98-110.

View in: PubMed
Singh SK, Lupo PJ, Scheurer ME, Saxena A, Kennedy AE, Ibrahimou B, Barbieri MA, Mills KI, McCauley JL, Okcu MF, Dorak MT. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016 Nov; 95(46):e5300.

View in: PubMed

People

Explore

Similar Concepts

Top Journals